Impact of Immunological Tests to Predict Relapse of Bullous Pemphigoid After Treatment Cessation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Real-life impact of the immunological tests to predict relapse after treatment cessation in patients with bullous pemphigoid: a French multicenter retrospective study
J Am Acad Dermatol 2022 Jan 25;[EPub Ahead of Print], G Battesti, C Garcia, M Viguier, V Marchal, M Castel, P Joly, AP Ledard, MP Konstantinou, V Seta, N Cordel, S Duvert-Lehembre, E Tancrède-Bohin, T Belmondo, S Ingen-Housz-Oro, M d'IncanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.